Announcement
Super Grannies and Market Update – June 30 Webinar Cancelled

Virus Still Receding, Millennial Investors’ Rising Influence

COVID-19 Progress has been mostly positive. Novavax and Johnson & Johnson both made progress on vaccines. AstraZeneca-Oxford’s vaccine was also approved by a European regulator. US daily cases are in a downward trajectory and may fall below 100,000 new cases a day in the next ten days. The ratio of vaccines to new cases is at 9x and could exceed 10x as early as next week. We are happy to report that COVID-19 cases have now been falling for 17 consecutive days. We are now definitely seeing

COVID-19 Progress has been mostly positive. Novavax and Johnson & Johnson both made progress on vaccines. AstraZeneca-Oxford’s vaccine was also approved by a European regulator. US daily cases are in a downward trajectory and may fall below 100,000 new cases a day in the next ten days. The ratio of vaccines to new cases is at 9x and could exceed 10x as early as next week. We are happy to report that COVID-19 cases have now been falling for 17 consecutive days. We are now definitely seeing the strongest retreat in cases since Wave 2.

...

Finish reading this report for free

Enter your email and we’ll send the paywall-free link directly to your inbox

In addition to your unlocked report, you will receive our weekly market newsletter FSI Snapshot, as well as occasional updates and offers from FS Insight. You can unsubscribe at any time. For more information, see our privacy policy.

Get unlimited access to Tom Lee’s Fundstrat research Subscribe
Already a member? Log in

More from the author

Disclosures (show)

Get invaluable analysis of the market and stocks. Cancel at any time. Start Free Trial

Articles Read 2/2

🎁 Unlock 1 extra article by joining our Community!

You are reading the last free article for this month.

By continuing, you agree to the Terms of Service and Privacy Policy.

Already have an account? Sign In

Trending tickers in our research

Get invaluable analysis of the market and stocks. Cancel at any time. Start Free Trial

Articles Read 2/2

🎁 Unlock 1 extra article by joining our Community!

You are reading the last free article for this month.

By continuing, you agree to the Terms of Service and Privacy Policy.

Already have an account? Sign In